Correspondent
White House correspondent, covers patent, trade and regulatory news
The United States Court of Appeals for the Fourth Circuit denied a petition for a writ of mandamus filed by Hamza Tebib. The court found that the record did not reveal undue delay by the district court Clerk in entering a default judgment.
The United States Court of Appeals for the Federal Circuit affirmed a Veterans Court order denying a motion to recall a prior mandate. The court held that the earlier decision did not conclusively determine the finality of a rating decision but instead remanded the issue for further consideration.
The United States Court of Appeals for the Federal Circuit affirmed a dismissal of a government contractor's protest. The court held the appellant lacked statutory standing and failed to file a timely protest under the Tucker Act.
The United States Court of Appeals for the Federal Circuit affirmed the judgment of the Court of Federal Claims in a nonprecedential ruling. The panel issued a per curiam decision without providing detailed reasoning.
The United States Court of Appeals for the Federal Circuit affirmed a Patent Trial and Appeal Board decision finding certain patent claims unpatentable as obvious. The court upheld the Board's construction of the term protocol and formatting information, rejecting the appellant's narrower interpretation.
The United States Court of Appeals for the Federal Circuit affirmed the decision of the Patent Trial and Appeal Board. This nonprecedential judgment resolves an appeal regarding patent validity challenges between two major athletic apparel companies.
The United States Court of Appeals for the Federal Circuit affirmed the Patent Trial and Appeal Board's decision in a nonprecedential ruling. The court issued a per curiam judgment without providing detailed reasoning.
The United States Court of Appeals for the Federal Circuit dismissed a petition for review of the Merit Systems Protection Board. The dismissal occurred because the petitioner failed to file a required Statement Concerning Discrimination.
The United States Court of Appeals for the Federal Circuit affirmed a district court ruling that Mylan Pharmaceuticals did not infringe Actelion Pharmaceuticals' patents for a stable epoprostenol drug formulation. The court held that the patent claim term requiring a pH of thirteen or higher refers to measurements taken at standard temperature, and that Actelion was barred from asserting infringement by equivalence.
The United States Court of Appeals for the Federal Circuit affirmed a district court ruling that a commercial agreement unambiguously incorporated a full contract of sale. The court held that the agreement's language required the defendant to indemnify the plaintiff for patent infringement claims arising in the United States, despite the contract limiting indemnification to the jurisdiction where title passed.
